Comparison of two chromogenic FVIII activity assays to a standard clot-based FVIII activity assay

被引：0
|
作者：
McGlasson, D. L. [1 ]
Fritsma, G. A. [2 ]
机构：
[1] 59th Clin Res Div, Lab Serv, Lackland AFB, TX USA
[2] Fritsma Factor, Hemostasis Connect, Birmingham, AL USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-235
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [31] Multi-national survey of FVIII activity assay practice
    Turecek, P. L.
    Apostol, C.
    Gritsch, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 55 - 55
  • [32] Factor VIII assessment using one-stage clot and chromogenic assay in trials investigating pharmacokinetics of different FVIII products
    Tiede, A.
    Ezban, M.
    Krogh-Meibom, T.
    Saugstrup, T.
    Moss, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 974 - 974
  • [33] The activity of glycoPEGylated recombinant FVIII (N8-GP) can be measured in both two-stage chromogenic and one-stage clotting assays
    Krogh-Meibom, T.
    Olsen, E. H. N.
    Kjalke, M.
    Ezban, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1042 - 1042
  • [34] Comparison of Post Treatment Monitoring of New And Old Factor VIII (FVIII) Therapeutic Products By One-Stage Clotting and Chromogenic FVIII Assays: Single Centre Experience
    Riddell, A.
    Gandhi, T.
    Vinayagam, S.
    Lawler, P.
    Pollard, T.
    Chowdary, P.
    HAEMOPHILIA, 2016, 22 : 86 - 87
  • [35] Prevalence of discrepancy between one-stage and chromogenic FVIII activity assays and the mutation profile in Polish mild/moderate haemophilia A patients
    Baran, Beata
    Odnoczko, Edyta
    Stefanska-Windyga, Ewa
    Pavlova, Anna
    Oldenburg, Johannes
    Windyga, Jerzy
    HAEMOPHILIA, 2016, 22 : 75 - 75
  • [36] Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates
    Devalet, Berangere
    Wannez, Adeline
    Bailly, Nicolas
    Alpan, Lutfiye
    Gheldof, Damien
    Douxfils, Jonathan
    Deneys, Veronique
    Bihin, Benoit
    Chatelain, Bernard
    Dogne, Jean-Michel
    Chatelain, Christian
    Mullier, Francois
    BLOOD TRANSFUSION, 2018, 16 (02) : 163 - 172
  • [37] Results from a multi-national survey of FVIII activity assay preferences
    Turecek, Peter L.
    Apostol, Claudia
    Gritsch, Herbert
    HAEMOPHILIA, 2016, 22 : 71 - 72
  • [38] FVIII inhibitors display FV-neutralizing activity in the prothrombin time assay
    Arsiccio, Andrea
    Beavis, James
    Raut, Sanj
    Coxon, Carmen H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (08) : 1907 - 1913
  • [39] Comparative study on ristocetin cofactor activity assay and two different collagen-binding-enzyme-linked immunosorbent assays for von Willebrand factor activity in VWF/FVIII-concentrates.
    Walter, O
    Budde, U
    Metzner, HJ
    Mueller, HG
    Muysers, C
    Suiter, TM
    BLOOD, 2002, 100 (11) : 101B - 102B
  • [40] High sensitivity fluorogenic substrate assay for FVIII activity measurement in human plasma samples
    Leong, L.
    Sommer, J.
    HAEMOPHILIA, 2008, 14 : 27 - 27
12345